Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 196 AL 210

FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease

Tanzi RE.

ACS Chem Neurosci. 2021 Aug 4;12(15):2714-2715. doi: 10.1021/acschemneuro.1c00394. Epub 2021 Jul 14.

Feasibility of improving strength and functioning and decreasing the risk of falls in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial

Cezar NOC, Ansai JH, Oliveira MPB, da Silva DCP, Gomes WL, Barreiros BA, Langelli TCO, de Andrade LP.

Arch Gerontol Geriatr. 2021 Sep-Oct;96:104476. doi: 10.1016/j.archger.2021.104476. Epub 2021 Jul 4.

Aducanumab for Alzheimer's disease: expediting approval and delaying science

Salinas RA.

BMJ Evid Based Med. 2021 Oct;26(5):214-215. doi: 10.1136/bmjebm-2021-111765. Epub 2021 Jul 14.

Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies

Salahuddin P, Khan RH, Furkan M, Uversky VN, Islam Z, Fatima MT.

Int J Biol Macromol. 2021 Sep 1;186:580-590. doi: 10.1016/j.ijbiomac.2021.07.056. Epub 2021 Jul 14.

Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials

Seibert M, Mühlbauer V, Holbrook J, Voigt-Radloff S, Brefka S, Dallmeier D, Denkinger M, Schönfeldt-Lecuona C, Klöppel S, von Arnim CAF.

Alzheimers Res Ther. 2021 Jul 16;13(1):131. doi: 10.1186/s13195-021-00867-8.

Recent advances in drug repurposing using machine learning

Urbina F, Puhl AC, Ekins S.

Curr Opin Chem Biol. 2021 Dec;65:74-84. doi: 10.1016/j.cbpa.2021.06.001. Epub 2021 Jul 16.

Photothermal and Photodynamic Therapies via NIR-Activated Nanoagents in Combating Alzheimer's Disease

Zeng F, Peng K, Han L, Yang J.

ACS Biomater Sci Eng. 2021 Aug 9;7(8):3573-3585. doi: 10.1021/acsbiomaterials.1c00605. Epub 2021 Jul 19.

Real-world Utilisation of the Rivastigmine Transdermal Patches Accompanying the Use of Risk Minimisation Tools in Patients with Dementia

Reinhardt F, Scarmeas N, Karan R, Veldandi UK, Modali S, Duvvuri K, Pathan RK.

Curr Alzheimer Res. 2021;18(4):273-282. doi: 10.2174/1567205018666210716120540.

Effects of Spices (Saffron, Rosemary, Cinnamon, Turmeric and Ginger) in Alzheimer's Disease

Seibel R, Schneider RH, Gottlieb MGV.

Curr Alzheimer Res. 2021;18(4):347-357. doi: 10.2174/1567205018666210716122034.

Aducanumab for Alzheimer's disease - too many unanswered questions

Phizackerley D.

Drug Ther Bull. 2021 Sep;59(9):130. doi: 10.1136/dtb.2021.000043. Epub 2021 Jul 20.

The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease

Ling TS, Chandrasegaran S, Xuan LZ, Suan TL, Elaine E, Nathan DV, Chai YH, Gunasekaran B, Salvamani S.

Biomed Res Int. 2021 Jul 4;2021:5550938. doi: 10.1155/2021/5550938. eCollection 2021.

Cognitive function improvement after fecal microbiota transplantation in Alzheimer's dementia patient: a case report

Park SH, Lee JH, Shin J, Kim JS, Cha B, Lee S, Kwon KS, Shin YW, Choi SH.

Curr Med Res Opin. 2021 Oct;37(10):1739-1744. doi: 10.1080/03007995.2021.1957807. Epub 2021 Aug 5.

Effects of Electrical Automatic Massage on Cognition and Sleep Quality in Alzheimer's Disease Spectrum Patients: A Randomized Controlled Trial

Kim YJ, Kim HR, Jung YH, Park YH, Seo SW.

Yonsei Med J. 2021 Aug;62(8):717-725. doi: 10.3349/ymj.2021.62.8.717.

Activity of Selected Group of Monoterpenes in Alzheimer's Disease Symptoms in Experimental Model Studies-A Non-Systematic Review

Wojtunik-Kulesza K, Rudkowska M, Kasprzak-Drozd K, Oniszczuk A, Borowicz-Reutt K.

Int J Mol Sci. 2021 Jul 8;22(14):7366. doi: 10.3390/ijms22147366.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias